Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
322
-
Total 13F shares, excl. options
-
90.1M
-
Shares change
-
+95.9K
-
Total reported value, excl. options
-
$5.95B
-
Value change
-
-$87M
-
Put/Call ratio
-
0.28
-
Number of buys
-
142
-
Number of sells
-
-202
-
Price
-
$66.24
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q1 2022
439 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q1 2022.
Guardant Health, Inc. - Common Stock (GH) has 322 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.1M shares
of 124M outstanding shares and own 72.71% of the company stock.
Largest 10 shareholders include FMR LLC (9.51M shares), VANGUARD GROUP INC (8.75M shares), VIKING GLOBAL INVESTORS LP (5.81M shares), MORGAN STANLEY (5.51M shares), BlackRock Inc. (5.1M shares), Capital International Investors (5.08M shares), Capital Research Global Investors (4.01M shares), Clearbridge Investments, LLC (3.35M shares), FRANKLIN RESOURCES INC (2.61M shares), and CREDIT SUISSE AG/ (1.82M shares).
This table shows the top 322 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.